Mirum Pharmaceuticals
MIRM
MIRM
171 hedge funds and large institutions have $1.34B invested in Mirum Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 69 increasing their positions, 53 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
10% less capital invested
Capital invested by funds: $1.49B → $1.34B (-$155M)
36% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 36
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
171
Holding in Top 10
4
Calls
$1.79M
Puts
$1.93M
Top Buyers
| 1 | +$27.3M | |
| 2 | +$17.7M | |
| 3 | +$16M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.9M |
| 5 |
CCM
Cadian Capital Management
New York
|
+$8.98M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$10.4M | |
| 3 | -$8.78M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.65M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$6.26M |